Skip to main content

Daniel Kelly Benjamin Jr.

Kiser-Arena Distinguished Professor
Pediatrics, Infectious Diseases
Duke Box 17969, Duke Clinical Research Institute, Durham, NC 27710
300 W Morgan St, Suite 800, Durham, NC 27701

Selected Grants


HEAL KIDS (Knowledge, Innovation and Discovery Studies) Pain Program Resource and Data Center

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2024 - 2030

Stimulating Access to Research in Residency (StARR) - NIAID

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2018 - 2029

NICHD Pediatric and Maternal Resource Center: Bridging Pharmacology and the Real World

ResearchPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2024 - 2028

National Career Development Program for Researchers in Pediatric Clinical Pharmacology

Inst. Training Prgm or CMECo-Principal Investigator · Awarded by National Institutes of Health · 2024 - 2028

Stimulating Access to Research in Residency (StARR) - NHLBI

Inst. Training Prgm or CMEPreceptor · Awarded by National Heart, Lung, and Blood Institute · 2018 - 2028

HEAL Clinical Coordinating Resource Center for the Pain Management Effectiveness Research Network

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2027

BPCA Innovative Trial Designs and Assay Developments in Pediatric Therapeutics

ResearchPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023 - 2026

UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program

Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2016 - 2026

Pediatric Trials Network_ Task Order 1_ Core Function Activities

ResearchPrincipal Investigator · Awarded by National Institute for Child Health & Human Develo · 2018 - 2026

Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2021 - 2026

Center for Innovative TRIals in ChilDrEN and AdulTs (TRIDENT)

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2016 - 2025

Core Function Activities 2.0

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2025

Duke CTSA (TL1) Year 5

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024

Duke Summer Training in Academic Research (Duke's STAR)

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2024

Duration of post-discontinuation antibiotic exposures in premature infants and associated outcomes

ResearchPrincipal Investigator · Awarded by Thrasher Research Fund · 2021 - 2024

ACTIV-1

Clinical TrialPrincipal Investigator · Awarded by Technical Resources International · 2020 - 2023

Bridging the Gap to Enhance Clinical Research Program (BIGGER)

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2016 - 2023

PTN 2.0 TO1 Core Function Activities - Option 4

ResearchPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2022 - 2023

PTN 2.0 TO 1 Core Function Activities_Option 3.1

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2022

PTN 2.0 TO 1 Core Function Activities_Option 3

ResearchPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2021 - 2022

ABCs of North Carolina Plan A

ResearchPrincipal Investigator · Awarded by NC Department of Public Instruction · 2021 - 2022

Mentoring Patient Oriented Research in Antibiotic-Resistant Bacteria

ResearchAdvisor · Awarded by National Institutes of Health · 2011 - 2022

UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program

Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2020 - 2021

PTN 2.0 TO 1 Core Function Activities_Option 2

Clinical TrialPrincipal Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2020 - 2021

Pharmacokinetics, Pharmacodynamics, and Safety of Methylprednisolone in Neonates on Cardiopulmonary Bypass

ResearchAdvisor · Awarded by National Institutes of Health · 2017 - 2020

Pediatric Trials Network_ Task Order 1_ Core Function Activities Option Period 1

ResearchPrincipal Investigator · Awarded by National Institute for Child Health & Human Develo · 2019 - 2020

Mentorship of early-career pediatricians in quantitative methods and therapeutics

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2019

Physiologically Based Pharmacokinetics in Critically Ill Children

Clinical TrialMentor · Awarded by National Institutes of Health · 2014 - 2019

UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program

Inst. Training Prgm or CMEPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2017 - 2019

SOLI - Solithromycin Pediatric Development Program (Phase 2/3)- Labor & Sub Cost

Clinical TrialCo Investigator · Awarded by Cempra Pharmaceuticals, Inc. · 2016 - 2018

Duke Research Training Program for Pediatricians

Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Institutes of Health · 2002 - 2018

PTN TO #34: Program Management Support - Option 2 Mod 1 (Mod 4)

Clinical TrialPrincipal Investigator · Awarded by National Institute for Child Health & Human Develo · 2017 - 2018

PTN TO #34: Program Management Support - Option 2

Clinical TrialPrincipal Investigator · Awarded by National Institute for Child Health & Human Develo · 2017 - 2018

PTN TO#47 (Protocol Development V)

ResearchPrincipal Investigator · Awarded by National Institute for Child Health & Human Develo · 2017 - 2018

Duke CTSA (UL1): Statistical methods for complex data in CV disease research

ResearchMentor · Awarded by National Institutes of Health · 2013 - 2018

NIH Summer Research Experience Programs (R25)

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2013 - 2018

PTN TO#42 HAP - Modification #1

Clinical TrialPrincipal Investigator · Awarded by National Institute for Child Health & Human Develo · 2016 - 2017

PTN TO#42 HAP

Clinical TrialPrincipal Investigator · Awarded by National Institute for Child Health & Human Develo · 2015 - 2017

Pediatric Trials Network

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2010 - 2017

PTN TO #34: Program Management Support

Clinical TrialPrincipal Investigator · Awarded by National Institute for Child Health & Human Develo · 2016 - 2017

PTN TO#14 (Mod #3) - Efficacy of sildenafil in premature infants with Pulmonary Hypertension

ResearchPrincipal Investigator · Awarded by National Institute for Child Health & Human Develo · 2015 - 2017

NRSA Training Grant for Clinical Pharmacology - Dallefeld and Chaparro

Inst. Training Prgm or CMEPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2016 - 2017

PTN Task Order #13: Pharmacokinetics of Antistaphylococcal Antibiotics in Infants

Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2017

Institutional Training Grant in Pediatric Infectious Disease

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2011 - 2016

PTN TO#40 (Protocol Development IV)

ResearchPrincipal Investigator · Awarded by National Institute for Child Health & Human Develo · 2015 - 2016

PTN Task Order #28 Baby Tape

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2014 - 2016

PTN Task Order #9: Midazolam

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2011 - 2016

The Duke Multidisciplinary Training Program in Pediatric Lung Disease

Inst. Training Prgm or CMECo-Principal Investigator · Awarded by National Institutes of Health · 2010 - 2016

PTN Task Order 34 - Program Management Support

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2015 - 2016

UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program

Inst. Training Prgm or CMEPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2011 - 2016

Phase I CTU Task Area A: Administrative and Overal Clinical Operations Support and Concept Development

Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2014 - 2015

PTN Task Order #5: Acyclovir

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2011 - 2015

PTN Task Order--Protocol Development III

Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2014 - 2015

PTN Task Order #16: Pediatrix Safety Study

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2015

PTN Task Order #15: Fluconazole Safety Trials

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2015

Pharmacokinetics and Pharmacodynamics of Antibiotics in Premature Infants

Clinical TrialMentor · Awarded by National Institutes of Health · 2010 - 2015

Multidisciplinary Neonatal Training Grant

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2010 - 2015

Institutional Training Grant in Pediatric Cardiology

Inst. Training Prgm or CMEFaculty Member · Awarded by National Institutes of Health · 2009 - 2015

PTN Task Order #24: Protocol Development II

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2013 - 2014

PTN Task Order #14: Sildenafil study

Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2014

Prevention of Invasive Candidiasis: PK, Safety, and Neurodevelopmental Outcomes

Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2008 - 2014

PTN Task Order #12 Protocol Development (RFTOPs)

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2014

PHARMACOKINETICS OF ANTIMICROBIAL AGENTS IN HIGH RISK INFANTS

ResearchCo-Mentor · Awarded by National Institutes of Health · 2009 - 2013

PTN Task Order #8: TAPE

Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2011 - 2013

PTN Task Order #10: Ampicillin

Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2011 - 2013

PTN Task Order #11: Obesity Informatics Database

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2011 - 2013

CTSA UL

ResearchCo Investigator · Awarded by National Institutes of Health · 2006 - 2012

Prevention of Invasive Candidiasis: PK, Safety, and Neurodevelopmental Outcomes

Clinical TrialPrincipal Investigator · Awarded by Food and Drug Administration · 2008 - 2012

Complement Regulates the Humoral Response to HIV-1

ResearchCollaborator · Awarded by National Institutes of Health · 2009 - 2011

North Carolina Collaborative PPRU Network

Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2004 - 2010

Best Pharmaceutical for Children Act (BPCA): Use of Meropenem in Infants

Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2007 - 2010

Early Diagnosis of Neonatal Candidiasis

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2005 - 2009

Clinical Predictors of Antiretroviral Failure

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2002 - 2004

External Relationships


  • AbbVie, Inc.
  • PPD
  • Syneos Health

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.